Literature DB >> 2004768

An approach to the use of stable isotopes for DNA sequencing.

K B Jacobson1, H F Arlinghaus, H W Schmitt, R A Sachleben, G M Brown, N Thonnard, F V Sloop, R S Foote, F W Larimer, R P Woychik.   

Abstract

The sequencing of DNA by current procedures involves the use of radioisotopic or fluorescent labels. We propose that stable isotopes can be used as such labels and that the large number of stable isotopes available would allow multiplexing so that many DNA segments could be sequenced simultaneously. We have developed methods to use 57Fe2O3 to synthesize ferrocene and to attach the ferrocene to the 5' end of oligonucleotides. The 57Fe-labeled M13 universal primer functioned normally in a Sanger sequencing procedure. When a 57Fe-labeled oligonucleotide had migrated on a polyacrylamide gel it was readily located on the dried gel by scanning with resonance ionization spectroscopy (RIS) coupled with mass spectrometry. Using a 57Fe-labeled primer in a PCR reaction a 2000-bp DNA was produced that was detected by RIS on nylon membrane after agarose electrophoresis. The rapid analysis features of RIS coupled with the multispectral multiplexing possibilities of stable isotopes should significantly increase the rate of determination of DNA sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004768     DOI: 10.1016/0888-7543(91)90220-9

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  A streptavidin-metallothionein chimera that allows specific labeling of biological materials with many different heavy metal ions.

Authors:  T Sano; A N Glazer; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  Enzymatic multiplex DNA sequencing.

Authors:  M Chee
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

3.  Impact of the human genome project on medical practice.

Authors:  B J Rossiter; C T Caskey
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.